CST3 and chronic kidney disease: In conclusion, current missing evidence for the clinical application of cystatin C to detect kidney disease in horses are: absence of assay validation data, absence of reference ranges, limited knowledge of extrarenal effects on cystatin C concentrations, only few studies on AKI and no studies of CKD available in the literature.